文献速递骨质疏松与代谢性骨病创伤骨科关节外科

高分辨率外周定量CT在成人中的临床应用:现状与未来方向

The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.
PubMed 文献 · Osteoporos Int · 2021-05-22

本文综述高分辨率外周定量CT(HR-pQCT)在成人中的临床应用现状与未来方向,涵盖年龄、性别、种族参考数据、骨折风险预测、抗骨质疏松治疗监测、代谢性骨病及新应用。HR-pQCT在多数正常或骨量减少的老年人群中可改善骨折预测,但超越髋部DXA的附加价值有限,未来需进一步研究药物效应、罕见骨病及新应用。

要点

  • HR-pQCT可评估外周骨微结构,在正常或骨量减少老年人群中改善骨折预测,但超越髋部DXA的附加价值有限。
  • 第二代HR-pQCT设备支持手关节成像、膝关节软骨下骨与软骨厚度评估及桡骨远端骨折愈合等新应用。
  • HR-pQCT在临床实践中的前景需进一步研究药物效应、代谢性骨病、罕见骨病等。

核心结论

  • HR-pQCT通过评估骨微结构改善骨折预测,但超越髋部DXA的附加价值有限。
  • HR-pQCT在临床实践中的前景需进一步研究药物效应、代谢性骨病、罕见骨病及手关节成像、骨折愈合等应用。
  • 尚未充分探索的潜力在于区分骨密度仅中度降低但微结构严重恶化的患者,这对治疗干预决策有重要意义。

研究设计与样本

  • 本文为综述,概述HR-pQCT在成人中的临床应用现状、结果解读指导及未来方向。
  • 综述涵盖年龄、性别和种族/民族差异及参考数据、骨折风险预测、抗骨质疏松治疗监测、代谢性骨病及继发性骨质疏松、新应用等方面。

主要发现

  • HR-pQCT在多数正常或骨量减少的老年人群中改善骨折预测,超越髋部DXA,但附加价值有限。
  • 第二代HR-pQCT设备允许手关节成像、膝关节软骨下骨和软骨厚度评估及桡骨远端骨折愈合等新应用。
  • HR-pQCT在临床实践中的广泛应用既面临挑战也存在机遇。

临床怎么用

  • HR-pQCT可用于评估骨微结构以改善骨折预测,但需认识到其超越髋部DXA的附加价值有限。
  • HR-pQCT可用于监测抗骨质疏松治疗反应、评估代谢性骨病及继发性骨质疏松,但需进一步研究。
  • 第二代HR-pQCT设备可用于手关节成像、膝关节软骨下骨和软骨厚度评估及桡骨远端骨折愈合评估。

局限性

  • HR-pQCT超越髋部DXA的附加价值有限。
  • HR-pQCT在临床实践中的广泛应用面临挑战。
  • HR-pQCT在药物效应、代谢性骨病、罕见骨病等方面的前景需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-resolution peripheral computed tomography (HR-pQCT) was developed to image bone microarchitecture in vivo at peripheral skeletal sites. Since the introduction of HR-pQCT in 2005, clinical research to gain insight into pathophysiology of skeletal fragility and to improve prediction of fractures has grown. Meanwhile, the second-generation HR-pQCT device has been introduced, allowing novel applications such as hand joint imaging, assessment of subchondral bone and cartilage thickness in the knee, and distal radius fracture healing. This article provides an overview of the current clinical applications and guidance on interpretation of results, as well as future directions. Specifically, we provide an overview of (1) the differences and reference data for HR-pQCT variables by age, sex, and race/ethnicity; (2) fracture risk prediction using HR-pQCT; (3) the ability to monitor response of anti-osteoporosis therapy with HR-pQCT; (4) the use of HR-pQCT in patients with metabolic bone disorders and diseases leading to secondary osteoporosis; and (5) novel applications of HR-pQCT imaging. Finally, we summarize the status of the application of HR-pQCT in clinical practice and discuss future directions. From the clinical perspective, there are both challenges and opportunities for more widespread use of HR-pQCT. Assessment of bone microarchitecture by HR-pQCT improves fracture prediction in mostly normal or osteopenic elderly subjects beyond DXA of the hip, but the added value is marginal. The prospects of HR-pQCT in clinical practice need further study with respect to medication effects, metabolic bone disorders, rare bone diseases, and other applications such as hand joint imaging and fracture healing. The mostly unexplored potential may be the differentiation of patients with only moderately low BMD but severe microstructural deterioration, which would have important implications for the decision on therapeutical interventions.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. van den Bergh JP, Szulc P, Cheung AM, et al. The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions. Osteoporos Int. 2021. PMID: 34023944. doi:10.1007/s00198-021-05999-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。